Article | August 16, 2022

CM Partnering For Adaptable, Accelerated Market Acceptance

Source: SMC Ltd.

By Cory Lee, project manager, SMC Ltd.

GettyImages-893884884-lab-research-team

The need for manufacturing support that offers adaptable, scalable solutions has become more crucial than ever for the diagnostic space. Challenges related to increasingly sensitive and costly drugs, as well as external factors related to the ongoing pandemic and supply chain constraints, have created complexities that are often best mitigated through the expertise and experience of a Contract Manufacturer (CM) able to adapt to an ever-changing market.

Recently, a leading diagnostics company that worked for years to develop its point-of-care (POC) testing technology for influenza and other viruses, was forced to pivot to COVID-19 testing at the start of the pandemic. Pressed for time and in need of rapid scale-up and turnaround, it engaged SMC Ltd. to manufacture components of its testing technology, working against tight timelines, labor constraints, and supply chain disruptions.

By utilizing its network of facilities and equipment, as well as plans to incorporate automation to address personnel shortages, SMC was able to establish a high-volume production plan and cut the required number of operators nearly in half through automation. As a result, SMC was successful in producing molded components and sub-assemblies for the testing cartridge systems, scaling production quickly and efficiently.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online